Dexamethasone for Croup and Bronchiolitis
Dexamethasone is highly effective and strongly recommended for croup at a dose of 0.15 mg/kg (maximum 10 mg) given as a single oral, intramuscular, or intravenous dose, but corticosteroids should NOT be used routinely for bronchiolitis as they provide no clinical benefit.
Croup Management
Dexamethasone Dosing and Administration
A single dose of 0.15 mg/kg dexamethasone is as effective as the traditional 0.6 mg/kg dose for treating croup of any severity 1, 2. This lower dose reduces potential adverse effects while maintaining full therapeutic benefit 3, 2.
- Dose: 0.15 mg/kg (maximum dose typically 10 mg, though some sources cite up to 12 mg for higher doses) 2, 4
- Routes: Oral, intramuscular, or intravenous—all are equally effective 1, 4
- Frequency: Single dose is sufficient; multiple doses do not improve outcomes and may prolong hospitalization 5
- Onset of action: Clinical benefit begins as early as 30 minutes, with statistically significant improvement by 30-60 minutes 3
Clinical Evidence for Croup
The evidence supporting dexamethasone in croup is robust. A 2023 Cochrane review including 45 RCTs with 5,888 children demonstrated that glucocorticoids significantly reduce croup scores at 2,6, and 12 hours compared to placebo 1. Dexamethasone reduces return visits and hospital admissions by approximately 45% compared to no treatment 1.
When comparing doses, 0.15 mg/kg versus 0.60 mg/kg showed no difference in:
- Croup scores at 2,6, or 12 hours 1
- Return visits or readmissions 1
- Need for additional treatments including epinephrine or intubation 1
- Length of hospital stay 1
Combination Therapy for Moderate to Severe Croup
For children with moderate to severe croup, nebulized epinephrine (racemic or L-epinephrine) should be added to dexamethasone 4.
- Racemic epinephrine: 0.05 mL/kg of 2.25% solution (maximum 0.5 mL) in 2 mL normal saline via nebulizer 6
- L-epinephrine alternative: 0.5 mL/kg of 1:1000 solution (maximum 5 mL) if racemic epinephrine unavailable 6
Important caveat: Epinephrine provides rapid but temporary relief (effects may last only 2 hours), so children must be observed for at least 2-3 hours after administration to ensure sustained improvement 4.
Bronchiolitis Management
Corticosteroids Are NOT Recommended
Corticosteroid medications should not be used routinely in the management of bronchiolitis 6. This is a strong recommendation based on multiple high-quality studies.
The 2006 American Academy of Pediatrics guideline explicitly states that corticosteroids have not been shown to be effective in improving the clinical course of bronchiolitis 6. A Cochrane systematic review of 13 studies with 1,198 patients found no significant benefit in:
- Length of hospital stay 6
- Clinical symptom scores 6
- Hospital admission rates 6
- Respiratory rate or oxygen saturation 6
Evidence Against Dexamethasone in Bronchiolitis
A large multicenter RCT of 600 infants (ages 2-12 months) with moderate-to-severe bronchiolitis found that a single 1 mg/kg dose of oral dexamethasone did not reduce hospital admission rates (39.7% vs 41.0% for placebo), did not improve respiratory status at 4 hours, and did not affect later outcomes 7.
Another study of 70 children showed initial benefit at 4 hours but no difference in respiratory scores by day 7, suggesting any early benefit is transient and clinically insignificant 8.
The 2014 AAP bronchiolitis guideline update reaffirmed that corticosteroids do not significantly reduce outpatient admissions or length of stay and should not be used 6.
Key Clinical Distinctions
Croup vs Bronchiolitis: Critical Differences
Croup (laryngotracheobronchitis):
- Upper airway inflammation affecting larynx, trachea, and bronchi 4
- Characterized by barking cough, inspiratory stridor, and hoarseness 4
- Age: typically 6 months to 3 years 4
- Treatment: Dexamethasone is highly effective 1, 4
Bronchiolitis:
- Lower respiratory tract infection affecting small airways 6
- Characterized by wheezing, tachypnea, crackles, and increased work of breathing 6
- Age: typically under 2 years, peak incidence under 12 months 6
- Treatment: Supportive care only; corticosteroids are ineffective 6
Common Pitfall to Avoid
Do not confuse croup with bronchiolitis—they require completely different management approaches regarding corticosteroids. The presence of stridor and barking cough indicates croup and warrants dexamethasone, while wheezing without stridor in a young infant suggests bronchiolitis where dexamethasone provides no benefit 6, 4.
Bronchiolitis Supportive Care
Since corticosteroids are ineffective, focus on: